▁The 10.375
▁study 10.625
▁conducted 6.0
▁a 5.1796875
▁correlation 7.5234375
▁type 5.83984375
▁of 1.8984375
▁research 4.16796875
▁with 3.72265625
▁variable 8.1328125
▁measures 8.1875
. 2.380859375
▁It 3.646484375
▁evaluated 7.37890625
▁the 0.96728515625
▁inter 6.0
dep 3.53125
end 0.00736236572265625
ence 0.01361083984375
▁of 0.55859375
▁various 4.0859375
▁factors 3.087890625
▁that 2.291015625
▁affected 4.10546875
▁the 0.609375
▁physical 7.11328125
▁and 1.4375
▁emot 3.712890625
ional 0.0025272369384765625
▁condition 4.328125
▁of 0.265869140625
▁patients 3.546875
▁experien 7.6171875
cing 0.0011386871337890625
▁chron 4.046875
ic 0.0031833648681640625
▁pain 1.2294921875
. 0.56103515625
▁For 5.5234375
▁example 2.017578125
, 0.10150146484375
▁the 1.865234375
▁survey 7.04296875
▁showed 3.109375
▁that 0.198486328125
▁the 2.193359375
▁ratio 8.0
▁of 0.11627197265625
▁female 3.736328125
▁patients 1.458984375
▁was 2.369140625
▁remark 9.5078125
ably 0.0013589859008789062
▁higher 0.814453125
▁in 2.548828125
▁the 1.875
▁op 8.0625
i 5.25390625
ates 0.462890625
▁group 2.025390625
▁compared 2.744140625
▁to 0.234619140625
▁the 0.452392578125
▁MM 10.875
▁group 4.95703125
. 0.423828125
▁In 3.150390625
▁turn 6.46875
, 0.0225830078125
▁people 7.06640625
▁on 5.24609375
▁op 1.2568359375
i 0.53515625
ates 0.002315521240234375
▁were 1.4951171875
▁more 1.2431640625
▁likely 0.36181640625
▁to 0.10345458984375
▁report 2.46875
▁major 7.0
▁de 0.51904296875
press 1.4873046875
ive 0.002979278564453125
▁dis 0.466552734375
orders 2.169921875
. 1.8369140625
<0x0A> 1.5322265625
The 1.62890625
▁analysis 5.29296875
▁of 1.0390625
▁any 8.8671875
▁human 5.5078125
▁reaction 5.48046875
▁has 4.1953125
▁a 2.068359375
▁high 4.9609375
▁potential 3.380859375
▁of 1.55859375
▁subject 6.515625
iveness 4.16796875
▁and 1.802734375
▁bias 2.1640625
, 1.9892578125
▁especially 2.6171875
▁regarding 5.19140625
▁people 4.18359375
▁in 3.888671875
▁severe 5.14453125
▁pain 0.72998046875
▁and 2.98828125
▁un 5.7109375
stable 1.81640625
▁emot 1.6708984375
ional 0.29736328125
▁condition 2.451171875
. 0.1236572265625
▁Perhaps 8.15625
▁some 4.89453125
▁patients 2.95703125
▁tend 6.359375
▁to 0.0175933837890625
▁ex 2.533203125
agger 0.002513885498046875
ate 0.006267547607421875
▁their 0.7060546875
▁de 7.6171875
press 0.873046875
ive 0.11114501953125
▁state 2.56640625
▁or 2.4609375
▁vice 6.84765625
▁vers 0.032928466796875
a 0.00012063980102539062
, 1.0595703125
▁de 7.265625
- 4.984375
emph 0.80078125
as 0.006591796875
ize 0.234130859375
▁serious 6.18359375
▁difficulties 6.41796875
. 1.1279296875
▁Because 5.9453125
▁the 2.44140625
▁survey 3.177734375
▁responses 7.515625
▁were 0.876953125
▁thoroughly 8.5390625
▁anonymous 5.03515625
, 0.3525390625
▁the 1.6201171875
▁research 2.234375
ers 0.359619140625
▁were 1.2548828125
▁unable 1.603515625
▁to 0.00528717041015625
▁carefully 8.7890625
▁analyze 1.740234375
▁each 3.791015625
▁patient 1.6318359375
’ 27.40625
s 3.671875
▁reaction 4.30859375
▁and 2.7421875
▁compare 3.943359375
▁it 0.744140625
▁to 0.92041015625
▁the 0.8037109375
▁actual 4.5
▁states 7.48828125
▁of 0.46435546875
▁condition 7.15625
. 0.456298828125
▁More 6.67578125
▁accurate 4.08203125
▁answers 5.01171875
▁could 2.251953125
▁be 1.005859375
▁obtained 0.9296875
▁by 1.2744140625
▁professional 7.4140625
▁psych 2.15625
olog 0.403564453125
ists 0.003269195556640625
▁via 7.92578125
▁personal 4.4375
▁communication 4.59375
▁and 2.24609375
▁behavior 7.12109375
al 0.331298828125
▁analysis 2.69921875
. 0.3125
▁However 2.869140625
, 0.00940704345703125
▁this 2.451171875
▁method 2.998046875
▁of 2.009765625
▁research 2.125
▁is 1.2470703125
▁way 7.5546875
▁more 1.92578125
▁resource 6.2109375
- 0.56884765625
int 0.55615234375
ensive 0.00959014892578125
▁and 0.7060546875
▁energy 9.2578125
- 0.2030029296875
consum 0.3427734375
ing 0.0026302337646484375
. 0.9296875
<0x0A> 0.89501953125
There 3.705078125
▁is 2.013671875
▁currently 5.31640625
▁a 1.5048828125
▁severe 5.2734375
▁lack 2.3984375
▁of 0.0216217041015625
▁information 3.169921875
▁about 1.29296875
▁the 0.66796875
▁effects 3.279296875
▁of 0.0765380859375
▁op 0.9130859375
i 1.0634765625
ates 0.001377105712890625
. 3.947265625
▁They 6.16015625
▁manage 8.875
▁pain 5.05078125
▁successfully 5.59765625
, 1.208984375
▁but 0.485595703125
▁the 2.341796875
▁past 9.859375
▁few 2.75390625
▁dec 0.671875
ades 0.0001423358917236328
▁indicated 7.9765625
▁the 2.3125
▁growing 3.841796875
▁concern 3.2265625
▁regarding 2.541015625
▁op 3.46484375
iate 0.325927734375
▁ab 1.4208984375
use 0.007781982421875
▁in 3.3359375
▁forms 10.3203125
▁of 0.1505126953125
▁over 3.3828125
d 0.3681640625
ose 0.2135009765625
▁and 0.76806640625
▁add 0.9091796875
iction 0.0307769775390625
. 0.1383056640625
▁A 4.3046875
▁more 4.97265625
▁manage 9.75
able 0.00237274169921875
▁and 2.00390625
▁sa 2.939453125
fer 8.976459503173828e-05
▁alternative 1.490234375
▁might 5.375
▁be 0.166015625
▁medical 5.1484375
▁mar 0.39697265625
iju 0.00365447998046875
ana 0.00020694732666015625
. 1.1181640625
▁However 3.14453125
, 0.008544921875
▁the 1.54296875
▁legal 3.529296875
▁status 1.36328125
▁and 2.8125
▁novel 9.4609375
ty 0.7333984375
▁of 0.16943359375
▁this 1.4443359375
▁drug 2.021484375
▁do 5.6171875
▁not 0.10791015625
▁allow 0.970703125
▁finding 8.7109375
▁a 2.21484375
▁large 5.09375
▁number 2.044921875
▁of 0.0033588409423828125
▁studies 1.84765625
▁on 1.7490234375
▁its 0.92236328125
▁effect 1.6982421875
iveness 0.1650390625
. 1.158203125
▁Specifically 8.203125
, 0.172607421875
▁it 2.814453125
▁concerns 5.5
▁the 0.763671875
▁emot 7.9296875
ional 0.007465362548828125
▁condition 2.26171875
▁of 0.390869140625
▁patients 0.5810546875
▁experien 1.8681640625
cing 7.617473602294922e-05
▁chron 0.223388671875
ic 0.00020837783813476562
▁pain 0.0222015380859375
. 0.369384765625
▁This 4.03515625
▁research 2.984375
▁paper 5.7734375
▁a 2.904296875
ims 0.000606536865234375
▁to 0.09832763671875
▁analyze 2.458984375
▁levels 10.8046875
▁of 0.047454833984375
▁de 0.7236328125
pression 0.18798828125
▁and 0.88623046875
▁anx 0.84716796875
iety 0.0010814666748046875
▁among 1.7265625
▁people 2.1953125
▁receiving 3.83203125
▁ther 6.33203125
apy 0.10498046875
▁by 5.12109375
▁comparing 8.0234375
▁the 1.20703125
▁effects 2.486328125
▁of 0.07672119140625
▁ph 6.14453125
arma 0.56494140625
ce 0.0029773712158203125
ut 0.0002772808074951172
ical 0.005718231201171875
▁op 1.173828125
io 3.009765625
ids 0.2078857421875
▁and 1.21484375
▁MM 6.77734375
. 1.5390625
<0x0A> 0.904296875
The 1.37109375
▁study 1.8876953125
▁was 2.142578125
▁conducted 0.5390625
▁in 1.4609375
▁the 1.6181640625
▁form 1.6787109375
▁of 0.00785064697265625
▁collection 9.78125
▁and 1.642578125
▁analysis 0.7412109375
▁of 0.029266357421875
▁statistical 4.0234375
▁data 0.11859130859375
. 0.8828125
▁Part 5.171875
icip 0.09747314453125
ants 0.05780029296875
▁were 0.69580078125
▁rec 3.484375
ru 0.0016851425170898438
ited 6.341934204101562e-05
▁for 3.931640625
▁six 7.94140625
▁months 0.591796875
▁at 3.84375
▁two 2.3828125
▁major 4.9296875
▁pain 2.791015625
▁relief 6.328125
▁cent 1.6650390625
ers 0.017578125
▁in 0.7666015625
▁Israel 4.8046875
. 0.32080078125
▁The 1.1875
▁research 2.599609375
ers 0.7646484375
▁used 2.896484375
▁The 7.91796875
▁De 5.703125
pression 0.0318603515625
▁Module 9.484375
▁of 0.91552734375
▁the 0.340087890625
▁Pat 2.537109375
ient 0.00875091552734375
▁Health 0.170166015625
▁Question 0.01428985595703125
naire 0.01885986328125
▁and 3.572265625
▁the 0.7705078125
▁General 1.751953125
ized 0.59423828125
▁An 0.01959228515625
x 0.00013911724090576172
iety 0.0019550323486328125
▁Dis 0.6572265625
order 0.048492431640625
▁Sc 1.228515625
ale 0.06658935546875
▁to 1.9873046875
▁interview 7.11328125
▁participants 2.236328125
, 3.669921875
▁evaluate 4.16796875
▁their 0.75048828125
▁answers 7.0
, 1.060546875
▁and 0.1544189453125
▁conduct 4.35546875
▁the 2.4765625
▁study 3.0859375
. 0.239990234375
▁To 5.00390625
▁specifically 9.1875
▁evaluate 1.830078125
▁and 4.37890625
▁compare 0.61328125
▁the 0.375732421875
▁prob 11.015625
abilities 0.2421875
▁of 0.1353759765625
▁de 1.3994140625
pression 0.2000732421875
▁or 3.78515625
▁anx 0.044769287109375
iety 0.0003829002380371094
▁among 1.9296875
▁the 2.18359375
▁diverse 9.125
▁groups 1.333984375
, 1.2421875
▁the 1.0009765625
▁study 2.94140625
▁used 1.66015625
▁multiple 4.359375
▁log 3.078125
istic 0.031951904296875
▁regression 0.10980224609375
▁analysis 0.5966796875
▁and 2.609375
▁chose 9.84375
▁medical 8.171875
▁mar 0.83349609375
iju 0.002010345458984375
ana 0.0019016265869140625
▁as 0.85400390625
▁the 0.6162109375
▁control 2.705078125
▁group 0.521484375
. 0.2325439453125
<0x0A> 0.7158203125
This 3.51171875
▁type 5.296875
▁of 0.009429931640625
▁study 2.18359375
▁is 1.375
▁the 3.119140625
▁most 1.78125
▁reve 8.765625
aling 0.0012149810791015625
▁and 0.81884765625
▁inclus 6.4140625
ive 0.003055572509765625
, 2.560546875
▁as 2.205078125
▁it 0.404541015625
▁contains 5.18359375
▁direct 6.26171875
▁responses 3.10546875
▁from 0.8037109375
▁a 4.015625
▁large 0.90185546875
▁number 0.431396484375
▁of 0.0034580230712890625
▁participants 1.705078125
. 0.58935546875
▁All 4.61328125
▁tools 9.8046875
▁in 4.86328125
▁the 0.810546875
▁form 3.869140625
▁of 0.047515869140625
▁question 1.81640625
na 0.050262451171875
ires 0.00018513202667236328
▁and 2.205078125
▁scales 2.783203125
▁have 3.509765625
▁already 4.71875
▁been 0.1785888671875
▁used 2.224609375
▁and 1.9677734375
▁proved 4.34375
▁their 1.86328125
▁effic 3.72265625
acy 0.0005898475646972656
▁for 3.36328125
▁collect 5.0703125
ing 0.01568603515625
▁analyt 8.5546875
ical 0.28564453125
▁data 0.27001953125
. 0.429443359375
▁It 3.806640625
▁helps 4.84375
▁to 1.0283203125
▁system 6.80078125
at 1.4912109375
ize 0.01094818115234375
▁and 1.51953125
▁class 4.22265625
ify 0.003204345703125
▁distinct 9.0234375
▁kinds 6.2734375
▁of 0.020904541015625
▁information 3.23046875
▁for 4.08203125
▁subsequent 4.03515625
▁un 7.83203125
comp 5.4453125
licated 0.0577392578125
▁services 12.53125
. 0.73681640625
▁Thus 4.57421875
, 0.031463623046875
▁research 4.4765625
ers 0.38720703125
▁can 1.935546875
▁compare 3.970703125
▁the 1.0869140625
▁effects 2.791015625
▁of 0.095947265625
▁medic 4.44140625
ations 0.81787109375
▁on 1.5625
▁patients 2.21484375
▁of 4.00390625
▁diverse 3.76171875
▁age 2.654296875
▁groups 0.91943359375
, 0.6826171875
▁background 4.8046875
s 0.3564453125
, 0.0888671875
▁physical 4.72265625
▁conditions 1.283203125
, 0.1256103515625
▁emot 3.298828125
ional 0.043609619140625
▁states 1.119140625
, 0.16943359375
▁and 0.47216796875
▁so 3.01953125
▁on 0.322509765625
. 0.057220458984375
<0x0A> 0.6640625
Am 6.8203125
ong 0.028167724609375
▁all 2.55078125
▁participants 2.541015625
▁in 3.25390625
▁the 0.314697265625
▁study 0.350341796875
, 0.0968017578125
▁ 0.9375
4 2.150390625
2 2.263671875
. 1.216796875
2 2.23046875
% 0.30419921875
▁suffered 5.01171875
▁from 0.07940673828125
▁de 0.88623046875
pression 0.1314697265625
, 1.1904296875
▁and 1.544921875
▁ 0.14990234375
3 1.6962890625
7 2.3125
% 2.677734375
▁experienced 2.74609375
▁excess 7.81640625
ive 0.1290283203125
▁anx 0.11553955078125
iety 0.0019931793212890625
. 0.1820068359375
▁The 1.5068359375
▁pl 10.71875
ur 0.86572265625
ality 0.00019097328186035156
▁of 0.1766357421875
▁de 4.14453125
press 1.50390625
ive 0.030914306640625
▁dis 2.529296875
orders 0.0751953125
▁among 3.693359375
▁patients 1.3720703125
▁in 3.26953125
▁the 0.473388671875
▁op 1.8671875
i 1.4951171875
ates 0.002201080322265625
, 6.78125
▁medical 3.345703125
▁mar 0.06439208984375
iju 0.0079498291015625
ana 0.00019681453704833984
, 0.4462890625
▁and 0.1317138671875
▁mixed 6.10546875
▁OP 9.2265625
MM 6.57421875
▁groups 0.63037109375
▁number 8.390625
ed 0.01122283935546875
▁ 0.12274169921875
5 2.3671875
7 2.5546875
. 0.2362060546875
1 2.33203125
%, 0.4833984375
▁ 0.0288238525390625
2 3.162109375
2 2.419921875
. 0.1236572265625
3 2.255859375
%, 0.1502685546875
▁and 0.03955078125
▁ 0.0035858154296875
5 3.08984375
1 2.48046875
. 0.1309814453125
4 2.115234375
%, 0.402099609375
▁respectively 0.01104736328125
. 0.0670166015625
▁The 1.5751953125
▁pl 3.498046875
ur 0.0202789306640625
ality 2.6941299438476562e-05
▁of 0.0399169921875
▁anx 0.86865234375
iety 0.01410675048828125
▁contained 11.296875
▁ 0.802734375
4 1.6162109375
8 2.3671875
. 0.050567626953125
4 2.302734375
% 0.572265625
▁among 1.642578125
▁OP 6.359375
▁patients 8.5
, 0.369384765625
▁ 0.1837158203125
2 1.5185546875
1 2.41015625
. 0.143310546875
5 2.470703125
% 0.014404296875
▁among 0.39990234375
▁MM 0.67138671875
▁patients 0.2281494140625
, 0.01898193359375
▁and 0.0191497802734375
▁ 0.04534912109375
3 1.2978515625
8 2.662109375
. 0.1390380859375
7 2.31640625
% 0.0152740478515625
▁among 0.2113037109375
▁OP 4.50390625
MM 0.265380859375
▁participants 3.732421875
. 0.049560546875
▁Pat 6.1484375
ients 0.024688720703125
▁who 2.646484375
▁took 2.83203125
▁strong 7.7734375
▁op 0.9287109375
i 1.171875
ates 0.0018415451049804688
▁were 1.7626953125
▁t 8.765625
ended 1.2685546875
▁to 0.011993408203125
▁place 10.375
▁their 3.927734375
▁pain 3.9921875
▁on 3.11328125
▁a 0.87060546875
▁scale 2.982421875
▁of 0.43701171875
▁ 0.460693359375
9 3.287109375
▁to 1.3876953125
▁ 0.01629638671875
1 0.037445068359375
0 0.07159423828125
▁( 2.9140625
Fe 9.9765625
ing 5.03515625
old 0.0077667236328125
▁et 1.6875
▁al 0.0270843505859375
., 0.460693359375
▁ 0.02569580078125
2 0.399658203125
0 0.0026397705078125
1 0.6337890625
7 2.396484375
). 0.1995849609375
▁They 3.587890625
▁were 1.0966796875
▁also 1.962890625
▁an 8.375
gu 4.5859375
ished 0.052154541015625
▁em 7.91015625
otion 0.01190948486328125
ally 0.0020961761474609375
▁and 1.14453125
▁react 7.05859375
ed 0.0482177734375
▁rad 9.515625
ically 0.0022525787353515625
▁neg 5.3984375
atively 0.0006003379821777344
▁to 0.390625
▁almost 5.30078125
▁all 1.044921875
▁survey 8.8359375
▁questions 0.716796875
. 0.3095703125
▁Pat 4.12109375
ients 0.008880615234375
▁who 1.193359375
▁took 1.00390625
▁only 6.125
▁MM 2.21484375
▁or 3.0390625
▁mixed 2.552734375
▁medic 2.908203125
ations 0.482421875
▁course 12.0
▁had 2.4609375
▁a 1.25390625
▁significantly 2.84375
▁more 3.984375
▁stable 2.876953125
▁emot 0.9716796875
ional 0.00826263427734375
▁state 0.9541015625
▁and 1.275390625
▁cop 5.8671875
ed 1.03125
▁with 0.7314453125
▁pain 1.73828125
▁more 1.458984375
▁manage 6.359375
able 2.421875
. 0.52099609375
<0x0A> 0.9091796875
Chr 7.21484375
onic 0.03863525390625
▁pain 0.13671875
▁is 1.0029296875
▁still 6.30078125
▁considered 2.509765625
▁to 2.140625
▁be 0.0247955322265625
▁an 2.390625
▁extreme 5.109375
▁issue 4.85546875
▁among 3.802734375
▁at 9.6875
▁least 0.48388671875
▁ 0.70361328125
8 2.544921875
% 3.791015625
▁of 0.05316162109375
▁the 0.51318359375
▁residents 8.2421875
▁of 0.58837890625
▁progress 12.28125
ive 0.42138671875
▁countries 0.857421875
. 0.72900390625
▁The 2.0703125
▁introduction 7.12109375
▁of 0.06475830078125
▁the 2.9375
▁study 5.3671875
▁describes 8.7578125
▁the 0.68408203125
▁apparent 8.0234375
▁link 4.3359375
▁between 0.2049560546875
▁pain 2.7578125
▁and 0.5439453125
▁dem 9.765625
oral 2.40625
ization 0.2744140625
. 0.92724609375
▁Chron 4.75
ic 0.005870819091796875
▁pain 0.12213134765625
▁is 1.3974609375
▁always 5.54296875
▁accompanied 0.88232421875
▁by 0.07763671875
▁negative 3.861328125
▁emot 0.56689453125
ional 1.10546875
▁experiences 4.78125
▁and 1.806640625
▁blocks 9.5625
▁a 3.24609375
▁person 0.67626953125
’ 25.296875
s 0.0516357421875
▁ability 1.2216796875
▁to 0.0200347900390625
▁receive 6.43359375
▁joy 4.87109375
▁and 1.34375
▁satisfaction 2.96484375
▁from 1.1162109375
▁life 0.984375
. 0.264404296875
▁The 2.013671875
▁research 3.1953125
▁investig 5.5078125
ates 0.580078125
▁the 0.40673828125
▁development 7.0078125
▁of 0.19775390625
▁de 1.5458984375
pression 0.369140625
▁and 0.45654296875
▁anx 0.1424560546875
iety 0.00211334228515625
▁among 1.2490234375
▁patients 0.8359375
▁receiving 1.970703125
▁ph 3.234375
arma 0.06353759765625
ce 0.0012178421020507812
ut 4.494190216064453e-05
ical 0.002857208251953125
▁op 0.783203125
io 0.875
ids 0.07464599609375
▁and 0.51025390625
▁medical 0.95556640625
▁mar 0.044281005859375
iju 0.00489044189453125
ana 9.036064147949219e-05
▁( 4.89453125
MM 1.8564453125
) 1.2666015625
▁as 2.048828125
▁severe 9.8515625
▁pain 2.04296875
kill 4.3671875
ers 0.00032806396484375
. 0.335205078125
▁It 2.083984375
▁comp 3.541015625
ares 0.020782470703125
▁the 0.403564453125
▁effic 5.1015625
acy 0.0007486343383789062
▁of 0.1658935546875
▁pres 5.65234375
cri 1.3564453125
ptions 0.397705078125
▁and 1.91796875
▁exam 4.87109375
ines 0.0145263671875
▁the 0.5224609375
▁possibility 4.10546875
▁of 0.08465576171875
▁post 8.3359375
- 1.1494140625
tre 1.1787109375
at 0.0008053779602050781
ment 0.00360870361328125
▁de 2.533203125
pression 0.11810302734375
. 2.31640625
<0x0A> 0.71142578125
One 5.25
▁of 0.4111328125
▁the 0.0214691162109375
▁major 2.55859375
▁limitations 3.875
▁is 3.263671875
▁the 0.415771484375
▁ins 4.78125
u 0.0249176025390625
fficient 0.160400390625
ly 4.5859375
▁high 2.771484375
▁response 2.515625
▁rate 0.14013671875
, 2.5859375
▁ 4.80859375
5 1.98828125
7 2.279296875
% 2.037109375
▁instead 7.6875
▁of 0.0076751708984375
▁ 0.63232421875
7 1.744140625
0 1.275390625
% 1.0966796875
▁( 2.357421875
Fe 1.7919921875
ing 0.01044464111328125
old 0.0007944107055664062
▁et 0.08026123046875
▁al 0.00328826904296875
., 0.0253143310546875
▁ 0.005863189697265625
2 0.0017671585083007812
0 0.0003223419189453125
1 0.005001068115234375
7 0.034698486328125
). 0.0528564453125
▁It 2.810546875
▁can 3.28515625
▁be 0.359619140625
▁fairly 8.4140625
▁explained 1.1875
▁by 0.1455078125
▁the 0.29931640625
▁weak 7.89453125
▁focus 6.9609375
▁of 0.473388671875
▁respond 5.80859375
ents 0.10693359375
▁who 3.79296875
▁have 3.658203125
▁overcome 8.0234375
▁severe 2.150390625
▁pain 0.442138671875
▁sens 8.6875
ations 1.3544921875
▁and 1.1494140625
▁de 4.23828125
press 1.6064453125
ive 0.272705078125
▁episodes 3.96484375
. 0.48291015625
▁It 3.275390625
▁is 0.87353515625
▁not 2.923828125
▁clear 4.02734375
▁how 1.62109375
▁to 3.318359375
▁use 5.39453125
▁these 3.46484375
▁statistics 2.89453125
, 2.435546875
▁as 1.3779296875
▁they 1.6376953125
▁still 6.203125
▁may 4.65625
▁be 1.154296875
▁relevant 5.9296875
▁for 1.4599609375
▁the 1.8701171875
▁overall 4.7734375
▁analysis 3.86328125
. 1.2109375
<0x0A> 1.89453125
Part 5.953125
icip 0.36865234375
ants 0.08966064453125
▁were 1.400390625
▁rec 1.947265625
ru 0.0010175704956054688
ited 6.985664367675781e-05
▁for 1.1337890625
▁six 0.89404296875
▁months 0.017730712890625
▁at 0.38037109375
▁two 0.0623779296875
▁major 0.35546875
▁pain 0.04669189453125
▁relief 0.044952392578125
▁cent 0.053466796875
ers 0.006465911865234375
▁in 0.0712890625
▁Israel 0.0246429443359375
. 0.1146240234375
▁All 4.2578125
▁patients 2.220703125
▁experienced 4.33203125
▁chron 2.14453125
ic 0.0012187957763671875
▁pain 0.0938720703125
▁for 3.3125
▁at 0.73095703125
▁least 0.00081634521484375
▁ 1.2314453125
3 1.390625
▁months 0.2274169921875
. 0.8544921875
▁The 1.1943359375
▁study 1.7021484375
▁included 3.130859375
▁ 1.501953125
8 3.029296875
9 2.794921875
0 3.4453125
▁participants 1.5234375
, 1.28125
▁of 1.857421875
▁which 0.447509765625
▁ 0.154541015625
4 1.20703125
7 3.33984375
4 2.685546875
▁( 2.251953125
5 0.09149169921875
9 10.609375
%) 0.9619140625
▁were 0.71337890625
▁treated 4.13671875
▁sole 6.96875
ly 0.00032067298889160156
▁with 0.63623046875
▁op 0.62939453125
io 1.427734375
ids 0.1483154296875
, 0.591796875
▁ 0.1650390625
3 1.4287109375
2 2.052734375
9 2.4296875
▁( 0.048797607421875
4 0.9599609375
1 1.1357421875
%) 0.12493896484375
▁were 1.6005859375
▁treated 0.603515625
▁with 0.2230224609375
▁MM 1.10546875
, 0.290283203125
▁and 0.1143798828125
▁ 0.07781982421875
7 2.884765625
7 2.4375
▁( 0.1627197265625
8 3.79296875
. 1.2724609375
6 2.81640625
%) 0.034912109375
▁acquired 10.1484375
▁both 1.453125
▁( 4.84375
Fe 0.451416015625
ing 0.005588531494140625
old 0.00039577484130859375
▁et 0.01480865478515625
▁al 0.00067138671875
., 0.00559234619140625
▁ 0.0016078948974609375
2 0.0005068778991699219
0 9.691715240478516e-05
1 0.00096893310546875
7 0.01087188720703125
). 0.018218994140625
▁The 1.4501953125
▁remaining 6.25390625
▁ten 7.953125
▁participants 1.39453125
▁who 5.26953125
▁did 1.5595703125
▁not 0.0067596435546875
▁receive 2.453125
▁ph 3.453125
arma 0.049468994140625
ce 0.0026493072509765625
ut 1.6689300537109375e-05
ical 0.004215240478515625
▁op 1.123046875
io 0.1263427734375
ids 0.027008056640625
▁and 1.6025390625
▁medical 1.12890625
▁mar 0.018463134765625
iju 0.003204345703125
ana 4.9948692321777344e-05
▁were 1.2587890625
▁with 5.9296875
dra 0.09979248046875
wn 5.626678466796875e-05
▁from 0.22607421875
▁the 0.09942626953125
▁analysis 3.572265625
▁in 4.8984375
▁the 1.2685546875
▁research 4.5703125
. 0.7109375
▁Therefore 5.1328125
, 0.01153564453125
▁it 3.08984375
▁is 0.61865234375
▁not 2.048828125
▁possible 0.8984375
▁to 0.0169525146484375
▁compreh 6.234375
ens 0.046875
ively 0.01128387451171875
▁compare 1.94140625
▁patients 4.921875
▁taking 3.392578125
▁medic 4.328125
ations 0.474365234375
▁with 1.3134765625
▁those 2.212890625
▁who 1.1552734375
▁do 2.232421875
▁not 0.011383056640625
. 0.94091796875
<0x0A> 0.5986328125
The 1.0810546875
▁question 5.2265625
na 1.2001953125
ires 8.702278137207031e-05
▁used 2.294921875
▁different 8.6875
▁variable 9.8359375
▁measures 2.74609375
▁to 1.6181640625
▁collect 2.072265625
▁information 2.119140625
. 1.6142578125
▁For 2.796875
▁example 0.26220703125
, 0.0080108642578125
▁it 4.37109375
▁included 2.765625
▁compreh 9.1328125
ensive 0.03662109375
▁so 6.8984375
cio 0.02447509765625
- 0.306884765625
dem 0.0789794921875
ographic 0.047393798828125
▁data 1.0751953125
: 4.9765625
▁gender 1.6064453125
, 0.1297607421875
▁age 0.2186279296875
, 0.10791015625
▁country 4.3203125
, 1.3076171875
▁type 4.0
▁of 0.051116943359375
▁residence 4.87890625
▁( 3.15625
urban 1.6962890625
/ 3.05078125
r 0.055755615234375
ural 0.00067901611328125
), 0.273193359375
▁years 6.3046875
▁of 0.1920166015625
▁education 0.890625
, 0.15087890625
▁and 1.7958984375
▁employ 3.794921875
ment 0.004039764404296875
▁status 0.449951171875
. 0.186767578125
▁Pat 3.85546875
ients 0.05804443359375
▁were 1.1748046875
▁also 0.97998046875
▁asked 0.68505859375
▁about 1.0498046875
▁their 0.70654296875
▁medical 2.8671875
▁history 0.392578125
▁over 8.7734375
▁the 0.18212890625
▁years 3.876953125
▁and 1.9443359375
▁the 1.8564453125
▁current 3.48046875
▁presence 5.84765625
▁of 0.0584716796875
▁any 2.794921875
▁severe 4.34375
▁dise 1.9345703125
ases 0.00014734268188476562
▁such 4.3203125
▁as 0.00646209716796875
▁heart 2.1875
▁failure 2.1171875
, 0.1798095703125
▁di 2.001953125
ab 0.0020294189453125
etes 0.004123687744140625
, 0.12744140625
▁ar 3.763671875
th 0.097412109375
rit 0.03607177734375
is 0.014251708984375
, 0.048248291015625
▁and 1.6240234375
▁so 0.92333984375
▁on 0.032958984375
. 0.054962158203125
▁The 1.82421875
▁third 6.9609375
▁measure 3.8671875
▁of 2.263671875
▁the 1.0830078125
▁question 2.46875
naire 0.1417236328125
▁was 0.85009765625
▁indicated 9.7109375
▁by 0.705078125
▁information 7.078125
▁on 1.5966796875
▁any 5.515625
▁twelve 13.6796875
- 1.3125
month 0.38525390625
▁and 5.8125
▁lifetime 3.17578125
▁drug 4.8203125
▁and 3.326171875
▁alco 0.06646728515625
hol 0.00010919570922851562
▁consumption 2.61328125
. 0.463623046875
▁In 3.5
▁addition 1.0029296875
, 0.1146240234375
▁the 1.3046875
▁record 8.234375
▁included 1.80859375
▁a 2.40625
▁pain 6.06640625
▁measurement 4.2890625
▁scale 0.93212890625
▁from 3.189453125
▁ 0.41162109375
0 0.9384765625
▁to 0.33837890625
▁ 0.0062713623046875
1 0.04364013671875
0 0.03924560546875
▁to 4.484375
▁evaluate 1.7939453125
▁dis 6.39453125
com 0.1490478515625
fort 0.002201080322265625
▁feelings 7.22265625
▁during 3.369140625
▁the 0.74755859375
▁last 1.943359375
▁month 1.708984375
. 0.316162109375
